Deepull

DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional status on the other hand. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus to provide a suitable clinical response even before the symptoms arise.

Deepull-logo
Team

Venture Capital

Status

Current

Geography

Europe

Financing Round

Seed

Segment

Diagnostic

Entry Date

2020

Key Figures

Current

Status

2019

Creation Date

2020

Investment Date

Pertinence Invest 2

Fund Name

Key Contacts

Related companies